Its considered one of the most important antioxidants in the human body
As an integral part of Tesamorelin, these amino acids facilitate its action as a synthetic growth-hormone-releasing hormone (GHRH)

The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al

Research around CJC-1295 and Ipamorelin includes experimental, investigational, and limited human-interest discussion, but evidence quality, clinical standards, and regulatory context can vary
2) The RIA test using polyclonal antibody recorded reduction in serum IGF-1 levels at 4, 8, and 16 weeks of age